Navigation Links
Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
Date:8/26/2013

(PRWEB) August 26, 2013

According to a Consumer Update released by the FDA on August 1, 2013, Tylenol and other medicines containing acetaminophen have been linked to Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). These “are the two most serious skin reactions linked in rare cases to acetaminophen” and “they usually require hospitalization and can cause death.” These reactions begin with flu-like symptoms followed by a rash. In some cases, the rash can blister and cover large areas of the body causing scarring. Dr. Sharon Hertz, a deputy director at the FDA, stated that “it is extremely important that people recognize and react quickly to the initial symptoms of these rare but serious, side effects, which are potentially fatal" (i).

The FDA reviewed its adverse events database and discovered that there had been 107 cases of SJS and TEN resulting in 67 hospitalizations and 12 deaths. Based on this evidence, the Agency is requiring all prescription medicines containing acetaminophen to add a warning about skin reactions on their labels. The Agency stated that it would work with over the counter manufacturers to get similar labels on their medicines. Accurate and uniform labeling is an important part of consumer safety but many people may not know which over the counter drugs contain acetaminophen because the name is often shortened as “APAP,” “acet,” “acetamin,” or “acetaminoph” (i).

Attorney Paul d’Oliveira stated, “Fortunately, the FDA is finally recognizing the danger of SJS and TEN among commonly used drugs like Tylenol. Unfortunately, it is alleged that some drug manufacturers do not warn about these risks on the labels of their medicines. For many years nobody questioned the safety of Tylenol but recent reports suggest that liver damage and SJS are real dangers. Our law firm is investigating the possible allegations of manufacturing defects, design defects, and failure to warn and working with lawyers who are litigating these cases.”

Side effects of Tylenol can be very serious in some cases. People who have suffered liver or SJS injuries may be entitled to compensation for medical bills, lost income, pain and suffering, scarring, disfigurement, loss of consortium, or wrongful death. d’Oliveira & Associates has been investigating the link between widely used medicines and hypersensitivity reactions like SJS and TEN. The law firm works with some of the more experienced Tylenol lawyers, who are handling these cases, and there is no legal fee until a settlement or award is obtained. To contact the firm call 1-800-992-6878 or submit a contact form online.

(i) FDA Consumer Update, August 1, 2013.
fda.gov/ForConsumers/ConsumerUpdates/ucm363010.htm

Read the full story at http://www.prweb.com/releases/2013/8/prweb11043687.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Why is traumatic brain injury increasing among the elderly?
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Experts Offer Advice After Yankee Pitchers Trampoline Injury
5. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
6. Mild traumatic brain injury may contribute to brain network dysfunction
7. Injury-Linked Deaths Vary Widely Among States
8. Most occupational injury and illness costs are paid by the government and private payers
9. Diabetes drug could be a promising therapy for traumatic brain injury
10. Brain-Injury Recovery Varies Widely Among Children
11. Traumatic brain injury the focus of American Headache Society scientific conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/27/2016)... NY (PRWEB) , ... June 27, 2016 , ... ... using cutting edge technology to revolutionize the emergency ambulance transport experience for the ... are aware of how Uber has disrupted the taxi industry through the use ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
Breaking Medicine Technology: